89-018-578
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin), Rabbit, Purified MaxPab™ Polyclonal Antibody, Abnova™
Manufacturer: Abnova Corporation
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 89-018-578-Each-of-1 | In Stock | ₹ 49,662.00 |
89-018-578 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 49,662.00
GST (18%): ₹ 8,939.16
Total Price: ₹ 58,601.16
Antigen
epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)
Classification
Polyclonal
Description
Rabbit polyclonal antibody raised against a full-length human EPM2A protein.
Gene
EPM2A
Gene Alias
EPM2/MELF
Host Species
Rabbit
Purification Method
Affinity Purified
Regulatory Status
RUO
Gene ID (Entrez)
7957
Content And Storage
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Isotype
IgG
Applications
Western Blot
Conjugate
Unconjugated
Formulation
PBS with no preservative; pH 7.4
Gene Accession No.
BC070047.1
Gene Symbols
EPM2A
Immunogen
EPM2A (AAH70047.1, 1 a.a. ∼ 331 a.a) full-length human protein.
Quantity
100 μg
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Related Products
Description
- This gene encodes a dual-specificity phosphatase that associates with polyribosomes
- The encoded protein may be involved in the regulation of glycogen metabolism
- Mutations in this gene have been associated with myoclonic epilepsy of Lafora
- Alternative splicing results in multiple transcript variants
- [provided by RefSeq Sequence: MRFRFGVVVPPAVAGARPELLVVGSRPELGRWEPRGAVRLRPAGTAAGDGALALQEPGLWLGEVELAAEEAAQDGAEPGRVDTFWYKFLKREPGGELSWEGNGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFKTEWDIVQNSSGCNRYPEPMTPDTMIKLYREEGLAYIWMPTPDMSTEGRVQMLPQAVCLLHALLEKGHIVYVHCNAGVGRSTAAVCGWLQYVMGWNLRKVQYFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVCSL